ACADIA Pharmaceuticals, Inc. (ACAD)
29.60
+0.02
(+0.07%)
USD |
NASDAQ |
Aug 27, 14:45
ACADIA Pharmaceuticals 1 Year Total Returns (Daily) : 15.01% for Aug. 26, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 26, 2026 | 15.01% |
| August 25, 2026 | 20.73% |
| August 24, 2026 | 15.19% |
| August 21, 2026 | 19.02% |
| August 20, 2026 | 16.44% |
| August 19, 2026 | 20.99% |
| August 18, 2026 | 20.43% |
| August 17, 2026 | 14.53% |
| August 14, 2026 | 15.12% |
| August 13, 2026 | 12.93% |
| August 12, 2026 | 15.72% |
| August 11, 2026 | 18.49% |
| August 10, 2026 | 19.47% |
| August 07, 2026 | 19.71% |
| August 06, 2026 | 19.54% |
| August 05, 2026 | 21.83% |
| August 04, 2026 | 12.94% |
| August 03, 2026 | 8.84% |
| July 31, 2026 | 8.56% |
| July 30, 2026 | 12.83% |
| July 29, 2026 | 16.39% |
| July 28, 2026 | 14.99% |
| July 27, 2026 | 9.20% |
| July 24, 2026 | 7.77% |
| July 23, 2026 | 6.70% |
| Date | Value |
|---|---|
| July 22, 2026 | 10.59% |
| July 21, 2026 | 14.14% |
| July 20, 2026 | 11.21% |
| July 17, 2026 | 13.53% |
| July 16, 2026 | 13.66% |
| July 15, 2026 | 17.76% |
| July 14, 2026 | 16.45% |
| July 13, 2026 | 21.54% |
| July 10, 2026 | 18.86% |
| July 09, 2026 | 22.44% |
| July 08, 2026 | 23.69% |
| July 07, 2026 | 25.48% |
| July 06, 2026 | 23.01% |
| July 02, 2026 | 22.27% |
| July 01, 2026 | 17.98% |
| June 30, 2026 | 17.29% |
| June 29, 2026 | 13.92% |
| June 26, 2026 | 14.00% |
| June 25, 2026 | 5.42% |
| June 24, 2026 | 4.24% |
| June 23, 2026 | 0.53% |
| June 22, 2026 | -2.73% |
| June 18, 2026 | -5.80% |
| June 17, 2026 | -5.26% |
| June 16, 2026 | -5.42% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Incyte Corp. | 52.52% |
| Agios Pharmaceuticals, Inc. | -11.62% |
| Biogen, Inc. | 61.70% |
| Insmed, Inc. | -5.89% |
| Vertex Pharmaceuticals, Inc. | 41.35% |